EUVIMEDEUVIMED entdecken
Crossref

The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment

Carmen Quirós, Nuria Alonso-Carril, Silvia Rodríguez-Rodríguez, Maria-José Barahona, Aida Orois, Andreu Simó-Servat, Montserrat Ramos, Verónica Perea

Endocrinología, Diabetes y Nutrición (English ed.) · 2023

DOI: 10.1016/j.endien.2022.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinología, Diabetes y Nutrición (English ed.), 2023. Verfasst von Carmen Quirós und 7 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Nutrition Department, Hospital Universitari Mútua de Terrassa, Spain. Electronic address: cquiros@mutuaterrassa.cat. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Improvements in continuous glucose monitoring (CGM) in recent years have changed the treatment of type 1 diabetes (T1D) by permitting the automation of glucose control. The Minimed 780G advanced hybrid closed-loop (ACHL) system adapts basal infusion rates and delivers auto-correction boluses in order to achieve a user-decided glucose target (100, 110 or 120mg/dL). This study set out to evaluate the effectiveness of the Medtronic 780G system in real-life conditions over 6 months. MATERIALS AND METHODS: Prospective study that included T1D subjects previously treated with insulin pump without CGM (pump group) or with sensor-augmented pump with predictive low-glucose suspend (SAP-PLGS group) who started with the Minimed 780G system. Sensor and pump data from baseline, and at 1, 3 and 6 months were downloaded and HbA1c was recorded at baseline and at 6 months. RESULTS: Fifty T1D subjects were included; 25 were previous SAP-PLGS 640G users and 25 used 640G without CGM. 66% were female, 48.6 (40-57) years of age with 20 (12-31.5) years of diabetes duration. Time in range (TIR) improved in the total cohort from baseline to 6 months (69% (57.7-76) vs. 74% (70-82); p=0.01 as did HbA1c (7.6% (7.1-7.8) vs. 7.0% (6.8-7.5); p 180 and >250mg/dL. Outcomes at 6 months did not differ between groups, although the SAP-PLGS subjects were prone to hypoglycaemia and the pump group mainly presented suboptimal metabolic control. CONCLUSION: The AHCL Medtronic Minimed 780G system achieves and maintains good glycaemic control over 6 months in real-life conditions in different profiles of T1D subjects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1AdultHumansFemaleYoung AdultMaleHypoglycemic AgentsGlycated HemoglobinInsulinBlood GlucoseBlood Glucose Self-MonitoringGlycemic ControlProspective StudiesGlucose

Stichwörter der Autor:innen

Closed-loop systemsDiabetes tipo 1Sistemas híbridos de asa cerradaTiempo en rangoTime in rangeType 1 diabetes

Substanzen

Hypoglycemic AgentsGlycated HemoglobinInsulinBlood GlucoseGlucose

Autor:innen und Institutionen

  • Endocrinology and Nutrition Department, Hospital Universitari Mútua de Terrassa, Spain. Electronic address: cquiros@mutuaterrassa.cat.
  • Endocrinology and Nutrition Department, Hospital Universitari Mútua de Terrassa, Spain.

Zitieren

APA

Quirós, C., Alonso-Carril, N., Rodríguez-Rodríguez, S., Barahona, M. J., Orois, A., Simó-Servat, A., Ramos, M., & Perea, V. (2023). The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment. Endocrinología, Diabetes y Nutrición (English ed.). https://doi.org/10.1016/j.endien.2022.10.005

Vancouver

Quirós C, Alonso-Carril N, Rodríguez-Rodríguez S, Barahona MJ, Orois A, Simó-Servat A, et al. The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment. Endocrinología, Diabetes y Nutrición (English ed.). 2023. doi:10.1016/j.endien.2022.10.005

BibTeX
@article{Quirs2023,
  author = {Quirós, Carmen and Alonso-Carril, Nuria and Rodríguez-Rodríguez, Silvia and Barahona, Maria-José and Orois, Aida and Simó-Servat, Andreu and Ramos, Montserrat and Perea, Verónica},
  title = {The Medtronic 780G advanced hybrid closed-loop system achieves and maintains good glycaemic control in type 1 diabetes adults despite previous treatment},
  journal = {Endocrinología, Diabetes y Nutrición (English ed.)},
  year = {2023},
  doi = {10.1016/j.endien.2022.10.005}
}
Kostenlos starten →